Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Bortnichak

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|April 10, 2004
Epidemiologists and adverse event data--a challenge to the fieldE A Bortnichak, W S Dai,
The American Journal of Medicine|November 28, 1986
An evaluation of spontaneous adverse drug reaction monitoring systemsR M Sachs, E A Bortnichak
The American Journal of Medicine|November 28, 1986
Piroxicam in recent epidemiologic studiesE A Bortnichak, R M Sachs
Pharmacoepidemiology and Drug Safety|August 15, 2001
Proactive safety surveillanceE A Bortnichak, R P Wise, M E Salive, et al.
Archives of Family Medicine|January 1, 1995
The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugsA M Walker, E A Bortnichak, L Lanza, et al.
Archives of Internal Medicine|July 10, 1995
Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort studyL L Lanza, A M Walker, E A Bortnichak, et al.
American Journal of Epidemiology|January 1, 1985
The association between cholesterol cholelithiasis and coronary heart disease in Framingham, MassachusettsE A Bortnichak, D H Freeman, A M Ostfeld, et al.
Pharmacoepidemiology and Drug Safety|September 1, 1996
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United StatesE A Andrews, J Avorn, E A Bortnichak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|April 10, 2004
Epidemiologists and adverse event data--a challenge to the fieldE A Bortnichak, W S Dai,
The American Journal of Medicine|November 28, 1986
An evaluation of spontaneous adverse drug reaction monitoring systemsR M Sachs, E A Bortnichak
The American Journal of Medicine|November 28, 1986
Piroxicam in recent epidemiologic studiesE A Bortnichak, R M Sachs
Pharmacoepidemiology and Drug Safety|August 15, 2001
Proactive safety surveillanceE A Bortnichak, R P Wise, M E Salive, et al.
Archives of Family Medicine|January 1, 1995
The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugsA M Walker, E A Bortnichak, L Lanza, et al.
Archives of Internal Medicine|July 10, 1995
Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort studyL L Lanza, A M Walker, E A Bortnichak, et al.
American Journal of Epidemiology|January 1, 1985
The association between cholesterol cholelithiasis and coronary heart disease in Framingham, MassachusettsE A Bortnichak, D H Freeman, A M Ostfeld, et al.
Pharmacoepidemiology and Drug Safety|September 1, 1996
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United StatesE A Andrews, J Avorn, E A Bortnichak, et al.
Pageof 1